Clinical Trial Update: Tipifarnib in Treating Older Patients With Previously Untreated Acute Myeloid Leukemia [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating tipifarnib for older patients with previously untreated acute myeloid leukemia has completed, with results reported.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• Tipifarnib (tipifarnib)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome, Adult Acute Basophilic Leukemia | Phase 2 | Status: COMPLETED